CAPPELLI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.461
EU - Europa 5.029
AS - Asia 2.610
SA - Sud America 275
OC - Oceania 114
AF - Africa 35
Totale 14.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.417
RU - Federazione Russa 2.313
HK - Hong Kong 790
SG - Singapore 757
IT - Italia 639
CN - Cina 609
PL - Polonia 593
IE - Irlanda 472
SE - Svezia 314
BR - Brasile 239
IN - India 184
DE - Germania 168
FI - Finlandia 164
AU - Australia 114
GB - Regno Unito 86
JO - Giordania 80
ID - Indonesia 70
FR - Francia 66
NL - Olanda 54
UA - Ucraina 37
VN - Vietnam 29
CH - Svizzera 27
ES - Italia 22
CA - Canada 21
BE - Belgio 15
TR - Turchia 13
CI - Costa d'Avorio 12
AT - Austria 11
IQ - Iraq 11
MX - Messico 11
AR - Argentina 10
JP - Giappone 10
KR - Corea 9
PK - Pakistan 9
PT - Portogallo 9
DK - Danimarca 8
ZA - Sudafrica 8
EC - Ecuador 7
VE - Venezuela 7
BD - Bangladesh 6
CO - Colombia 5
KE - Kenya 5
RS - Serbia 5
UZ - Uzbekistan 5
GR - Grecia 4
MY - Malesia 4
PA - Panama 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
HN - Honduras 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
RO - Romania 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MU - Mauritius 2
PH - Filippine 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 14.524
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.604
Hong Kong 693
Warsaw 586
Fairfield 488
Singapore 485
Dublin 470
Ashburn 327
Chandler 252
Woodbridge 200
Seattle 183
Houston 179
Cambridge 160
Wilmington 145
Moscow 125
Florence 111
Melbourne 109
Hefei 103
Lawrence 103
Altamura 100
Beijing 100
Ann Arbor 93
Princeton 74
Jakarta 70
Helsinki 68
Mumbai 68
Shanghai 64
New York 61
Munich 57
Bengaluru 55
Buffalo 54
San Diego 47
Boston 44
Milan 44
Medford 42
Los Angeles 40
Rome 39
Turku 38
West Jordan 36
Lappeenranta 31
Kent 30
Paris 30
London 27
Yubileyny 25
Dong Ket 24
Pune 24
Boardman 22
Frankfurt am Main 22
Jacksonville 22
Naples 22
Guangzhou 21
Bern 20
Düsseldorf 16
Hillsboro 16
Prato 15
São Paulo 15
Brussels 14
Falls Church 13
New Delhi 13
Redwood City 13
Rio de Janeiro 13
Abidjan 12
Pisa 12
Dnipro 11
Amsterdam 10
Barcelona 10
Siena 10
Zhengzhou 10
Brooklyn 9
Chennai 9
Falkenstein 9
Norwalk 9
The Dalles 9
Washington 9
Copenhagen 8
Seoul 8
Toronto 8
Belo Horizonte 7
Bologna 7
Izmir 7
Livorno 7
Phoenix 7
Baghdad 6
Delray Beach 6
Genoa 6
Johannesburg 6
Montreal 6
Wroclaw 6
Wuhan 6
Xi'an 6
Baoding 5
Belgrade 5
Brasília 5
Carmignano 5
Changsha 5
Dalian 5
Denver 5
Groningen 5
Kilburn 5
Lisbon 5
Nairobi 5
Totale 9.256
Salva come PNG Salva come JPEG
Nome #
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: An Italian perspective 232
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon 229
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy 212
Heart failure with mid-range ejection fraction: Current evidence and uncertainties 176
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 171
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis 170
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis. 169
Different NT-proBNP circulating levels for different types of cardiac amyloidosis 169
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 154
Cerebral Fat Embolism After Video-Assisted Thoracic Surgery 152
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 148
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 147
Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. 142
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 142
Troponins in cardiac amyloidosis: multipurpose markers. 141
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis 137
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 135
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 135
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy 131
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 131
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 128
Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging 126
Anxiety and depression among AL amyloidosis patients: The role of cardiac symptoms 125
Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: The role of life satisfaction. 125
Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates 124
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study 122
Cardiac amyloidosis: the heart of the matter. 119
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients 118
ECG abnormalities, atrial fibrillation and AV blocks in ATTR VS AL amyloidosis: an electrophysiological natural history 115
Atrial standstill disease progression documented after 13 years follow-up 115
Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis 114
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 113
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 112
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant 110
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 109
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis 109
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 108
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 108
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 108
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 107
A Man in His 80s with Hypertension, Left Ventricular Hypertrophy, and Enlarged Biceps 106
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 103
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 103
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty 102
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 100
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis 98
Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it 98
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 97
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 97
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis. 96
Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. 96
Chest pain and mild left ventricular hypertrophy: a challenging diagnosis 96
Cardiac amyloidosis: the heart of the matter. 95
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience 94
Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation. 93
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 92
Rotational mechanics of the left ventricle in AL amyloidosis. 90
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 90
Temporal Variation in Optimal Atrioventricular and Interventricular Delay During Cardiac Resynchronization Therapy 88
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 88
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 87
Screening for cardiac amyloidosis in patients with tenosynovial red flags: A collaboration between family medicine and cardiology 87
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 87
Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. 87
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 87
Clinical pathway for cardiomyopathies: A genetic testing strategy proposed by ANMCO in Tuscany 86
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry 86
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus 86
Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis 85
Prognostic value of fragmented QRS in cardiac AL amyloidosis 85
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 85
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 84
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 83
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 83
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 83
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy 82
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 81
Multicentre multi-device hybrid imaging study of coronary artery disease: Results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population 81
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 81
Right ventricular function in AL amyloidosis: characteristics and prognostic implication. 81
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 80
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 80
Concordant Versus Discordant Left Bundle Branch Block in Heart Failure Patients: Novel Clinical Value of an Old Electrocardiographic Diagnosis 80
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 80
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 80
[Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit] 80
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 80
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 78
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 78
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 78
Wild-Type ATTR Amyloidosis 77
Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? 77
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 77
Asymptomatic homozygous gene carrier in a family with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany? 77
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 76
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 76
A multidisciplinary case of multiple myeloma with cardiac and renal involvement: a look beyond amyloidosis 76
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 75
Standard Therapy in Cardiac Amyloidosis 75
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 75
Totale 10.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 0 0 0 23
2020/2021796 41 59 32 130 74 75 36 60 85 113 49 42
2021/2022567 16 27 20 20 18 39 15 34 44 97 80 157
2022/20231.796 99 319 88 77 124 319 337 103 186 31 72 41
2023/20241.381 24 116 135 59 112 171 61 334 39 136 102 92
2024/20258.685 292 879 475 1.372 2.236 1.156 222 437 438 231 498 449
Totale 14.788